The purpose of this study is to study the molecular effects of the chemopreventative agent,
finasteride, in combination with dietary soy supplementation in patients at high risk for the
development of prostate cancer. Also, the investigators intend to create a large database
with health information from men who are at high risk of developing prostate cancer, along
with serum and tissue samples from those patients who are willing to provide tissue and serum
samples.